Medication Use for Obesity-Related Comorbidities After Sleeve Gastrectomy or Gastric Bypass
Howard R, Chao G, Yang J, Thumma J, Arterburn D, Telem D, Dimick J. Medication Use for Obesity-Related Comorbidities After Sleeve Gastrectomy or Gastric Bypass. JAMA Surgery 2022, 157: 248-256. PMID: 35019988, PMCID: PMC8756362, DOI: 10.1001/jamasurg.2021.6898.Peer-Reviewed Original ResearchConceptsTime of surgeryGastric bypassMedication discontinuationSleeve gastrectomyCumulative incidenceMedication useHyperlipidemia medicationsComorbidity resolutionLower incidenceCommon bariatric surgical proceduresLipid-lowering medication useComparative effectiveness research studyAdult Medicare beneficiariesDiabetes medication useAntihypertensive medication useLipid-lowering medicationsBariatric surgical proceduresSubset of patientsLong-term trialsAntihypertensive medicationsDiabetes medicationsLaparoscopic RouxBariatric surgeryPrimary outcomeMean age